DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for the three months ended April 1, 2023. Q1 Financial Summary: Net Sales of $119.1 million, up $1.8 million, or 1.5%, year-over-year…Read More
Bioventus Inc Bioventus Reports First Quarter Financial Results
